Publication: The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
Issued Date
2012-05-29
Resource Type
ISSN
14752875
Other identifier(s)
2-s2.0-84861439370
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Malaria Journal. Vol.11, (2012)
Suggested Citation
Kesinee Chotivanich, Mathirut Mungthin, Ronnatrai Ruengweerayuth, Rachanee Udomsangpetch, Arjen M. Dondorp, Pratap Singhasivanon, Sasithon Pukrittayakamee, Nicholas J. White The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum. Malaria Journal. Vol.11, (2012). doi:10.1186/1475-2875-11-177 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/14317
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
Abstract
Background: Lumefantrine and atovaquone are highly lipophilic anti-malarial drugs. As a consequence absorption is increased when the drugs are taken together with a fatty meal, but the free fraction of active drug decreases in the presence of triglyceride-rich plasma lipoproteins. In this study, the consequences of lipidaemia on anti-malarial drug efficacy were assessed in vitro. Methods: Serum was obtained from non-immune volunteers under fasting conditions and after ingestion of a high fat meal and used in standard Plasmodium falciparum in-vitro susceptibility assays. Anti-malarial drugs, including lumefantrine, atovaquone and chloroquine in five-fold dilutions (range 0.05 ng/ml 1 ug/mL) were diluted in culture medium supplemented with fasting or post-prandial 10% donor serum. The in-vitro drug susceptibility of parasite isolates was determined using the 3 H-hypoxanthine uptake inhibition method and expressed as the concentration which gave 50% inhibition of hypoxanthine uptake (IC 50 ). Results: Doubling plasma triglyceride concentrations (from 160 mg/dL to 320 mg/dL), resulted in an approximate doubling of the IC 50 for lumefantrine (191 ng/mL to 465 ng/mL, P < 0.01) and a 20-fold increase in the IC 50 for atovaquone (0.5 ng/mL to 12 ng/ml; P < 0.01). In contrast, susceptibility to the hydrophilic anti-malarial chloroquine did not change in relation to triglyceride content of th e medium. Conclusions: Lipidaemia reduces the anti-malarial activity of lipophilic anti-malarial drugs. This is an important confounder in laboratory in vitro testing and it could have therapeutic relevance. Keywords: Malaria, Anti-malarial drugs, In vitro-susceptibility © 2012 Chotivanich et al.; licensee BioMed Central Ltd.